Insiders · CLDI

CLDI insider transactions

Calidi Biotherapeutics Inc. (CLDI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CLDI

• 173d
  Director Camaisa Allan sold $1,237 worth of shares (850 units at $1.46) (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 275d
  SEC Form 4 filed by Chief Executive Officer Poma Eric E

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 275d
  SEC Form 4 filed by Chief Scientific Officer Fernandez Santidrian Antonio

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 275d
  SEC Form 4 filed by Chief Financial Officer Jackson Andrew C.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 285d
  New insider Lincoln Alternative Strategies Llc claimed ownership of 730,000 shares (SEC Form 3)

  3 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 286d
  Chief Financial Officer Jackson Andrew C. bought $5,000 worth of shares (2,500 units at $2.00) (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 286d
  Chief Executive Officer Poma Eric E bought $50,000 worth of shares (25,000 units at $2.00) (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 286d
  Director Leftwich Scott bought $250,000 worth of shares (125,000 units at $2.00), increasing direct ownership by 2,212% to 130,650 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 286d
  Director Schoeneck James A bought $150,000 worth of shares (75,000 units at $2.00), increasing direct ownership by 6,614% to 76,134 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 327d
  SEC Form 4 filed by Director Leftwich Scott

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 327d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 327d
  SEC Form 4 filed by Director Schoeneck James A

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 327d
  SEC Form 4 filed by Director Stewart Alan R.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 409d
  SEC Form 4 filed by Chief Executive Officer Poma Eric E

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 409d
  SEC Form 3 filed by new insider Poma Eric E

  3 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 520d
  Director Stewart Alan R. was granted 12,771 shares, increasing direct ownership by 79% to 28,976 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 520d
  Director Leftwich Scott was granted 11,684 shares, increasing direct ownership by 21% to 67,774 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 536d
  CEO and Chairman of the Board Camaisa Allan sold $16,200 worth of shares (10,000 units at $1.62), decreasing direct ownership by 13% to 66,712 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 600d
  SEC Form 4 filed by Director Stewart Alan R.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 600d
  SEC Form 4 filed by Director Leftwich Scott

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 600d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 600d
  SEC Form 4 filed by Director Schoeneck James A

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 615d
  CEO and Chairman of the Board Camaisa Allan was granted 70,155 shares (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 696d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 696d
  SEC Form 3 filed by new insider Peoples George

  3 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 705d
  Director Leftwich Scott was granted 67,187 shares, increasing direct ownership by 14% to 560,873 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 705d
  Director Schoeneck James A was granted 79,687 shares, increasing direct ownership by 8% to 1,071,781 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 705d
  Director Stewart Alan R. was granted 73,437 shares, increasing direct ownership by 91% to 154,087 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 705d
  Director Leftwich Scott was granted 23,783 shares, increasing direct ownership by 5% to 493,686 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 705d
  Director Schoeneck James A was granted 28,207 shares, increasing direct ownership by 3% to 992,094 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 705d
  Director Stewart Alan R. was granted 25,995 shares, increasing direct ownership by 48% to 80,650 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 717d
  SEC Form 4 filed by Chief Financial Officer Jackson Andrew C.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 717d
  SEC Form 4 filed by CEO and Chairman of the Board Camaisa Allan

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 717d
  SEC Form 4 filed by Chief Admin. and Legal Officer Campbell Wendy Pizarro

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 717d
  SEC Form 4 filed by Interim Chief Medical Officer Minev Boris Radoslavov

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 733d
  Schoeneck James A exercised 548,000 shares at a strike of $0.20 (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 776d
  Schoeneck James A was granted 375,000 shares (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 817d
  SEC Form 3 filed by new insider Lapre David

  3 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)